Advagen Pharma Europe OÜ
Advagen Pharma Europe OÜ is a OÜ based in Tallinn, registry code 16738127, status: active. Main activity: Manufacture of pharmaceutical preparations. According to EMTA, turnover for Q3 2026 was €0 with employees.
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Revenue · 2024 354 702 €above 61% of companiesindustry median 25 284 € · companies in the industry: 24
- Net profit margin · 2024 1.9 %above 56% of companiesindustry median 1.2 % · companies in the industry: 17
Taxes and turnover
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | — | — | — | — |
| Q2 2026 | — | — | — | — |
| Q1 2026 | — | — | — | — |
| Q4 2025 | — | — | — | — |
| Q3 2025 | — | — | — | — |
| Q2 2025 | — | — | — | — |
| Q1 2025 | — | 58 | — | — |
| Q4 2024 | — | — | — | — |
| Q3 2024 | — | — | — | — |
| Q2 2024 | — | — | — | — |
| Q1 2024 | — | — | — | — |
| Q4 2023 | — | — | — | — |
| Q3 2023 | — | — | — | — |
| Q2 2023 | — | — | — | — |
Financials by year
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2024 | 354 702 | 6 715 | 0 | 2 226 759 | 6 715 | 0 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2024
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2023 | 15 May 2023 – 31 Mar 2024 | 2 May 2025 | Company’s own | e-Äriregister |
Board
- Nitin JajodiaBoard member · since 16 May 2025
- Parag Suganchand SanchetiBoard member · since 16 May 2025
- Pratibha Sudhir PilgaonkarBoard member · since 16 May 2025
- Sagar Pradeep OakBoard member · since 16 May 2025
- Varun Vinayak KulkarniBoard member · since 16 May 2025
- InCorpora OÜContact person · since 16 May 2025
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Rubicon Research LimitedLegal person · 0 €
Beneficial owners
- Parag Suganchand SanchetiMember of a senior management body (management or supervisory board) · IND · since 21 May 2025
Founders and other persons
- Rubicon Research Private LimitedFounder · 0 € · 9 May 2023
Activities (EMTAK)
- 21201Manufacture of pharmaceutical preparations Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 50228219 / 7 28 May 2025 |
Amendment entry | In force 28 May 2025 |
||
| Ä 50228219 / 6 16 May 2025 |
Amendment entry | In force 16 May 2025 |
||
| Ä 50228219 / 5 8 May 2025 |
Amendment entry | In force 8 May 2025 |
||
| Ä 50228219 / M7 7 May 2025 |
Ruling to eliminate deficiencies | 27 May 2025 | Deficiencies eliminated 9 May 2025 |
|
| Ä 50228219 / M6 7 Apr 2025 |
Ruling to eliminate deficiencies in the annual report | 7 May 2025 | Deficiencies eliminated 2 May 2025 |
|
| Ä 50228219 / M5 2 Apr 2025 |
Ruling to eliminate deficiencies | 18 Apr 2025 | In force 22 Apr 2025 |
|
| Ä 50228219 / M4 11 Nov 2024 |
Warning of deletion from the register: annual report not filed | 14 Feb 2025 | Deficiencies eliminated 29 Jan 2025 |
|
| Ä 50228219 / 4 20 Jun 2024 |
Amendment entry | In force 20 Jun 2024 |
||
| Ä 50228219 / M3 17 Jun 2024 |
Ruling to eliminate deficiencies | Deficiencies eliminated 20 Jun 2024 |
||
| Ä 50228219 / M2 20 May 2024 |
Warning of deletion from the register: contact person not as required | 23 Aug 2024 | Deficiencies eliminated 21 Jun 2024 |
|
| Ä 50228219 / 3 5 May 2024 |
Amendment entry | In force 5 May 2024 |
||
| Ä 50228219 / 2 2 Sep 2023 |
Amendment entry | In force 2 Sep 2023 |
||
| Ä 50228219 15 May 2023 |
First entry | In force 15 May 2023 |
||
| Ä 50228219 / M1 10 May 2023 |
Ruling to eliminate deficiencies | 1 Jun 2023 | Deficiencies eliminated 15 May 2023 |
Sources: e-Äriregister and EMTA. Data updated 2 Nov 2026. Open at the source ↗ · Report an error in the data